IL10 and severe acute respiratory syndrome: However, COVID-19 patients also present with increased anti-inflammatory cytokines (IL-4, IL-10), that differ from those in SARS-CoV infection.24,53 The Univariate Cox Analysis by Yanget al. indicated that circulating IL-6 significantly predicted the progression of COVID-19 infection.